Project: Fighting Leukemia with the Original Radioimmunotherapy Alpha37 (FLORA)

Acronym FLORA (Reference Number: 113345)
Duration 31/10/2019 - 02/05/2021
Project Topic We will develop a novel drug with potential to become the next generation radioimmunotherapy (RIT) for treatment of resistant or refractory (R/R) chronic lymphocytic leukemia (CLL) patients - from current preclinical stage via GMP production development to approved application for phase 1 clinical trial. FLORA will deliver the first RIT treatment for CLL which has greater effectiveness, fewer side effects and is easier to use by patients who become resistant or refractory to available therapies.
Network Eurostars 2
Call Eurostars Cut–off 11

Project partner

Number Name Role Country
1 Nordic Nanovector ASA Coordinator Norway
2 Orano Med SAS Partner France